Skip to main content

Table 2 Multivariate Cox regression analyses for biochemical failure in the entire cohort (n = 1176)

From: Comparison between preoperative and real-time intraoperative planning 125I permanent prostate brachytherapy: long-term clinical biochemical outcome

Factor

Model 1

Model 2

 

Hazard ratio (95% CI)

p-value

Hazard ratio (95% CI)

p-value

Age

0.99 (0.94–1.03)

0.49

1.01 (0.95–1.07)

0.78

PSA

1.09 (1.02–1.17)

0.011

1.08 (0.96–1.22)

0.22

Gleason

1.02 (0.72–1.46)

0.90

1.55 (0.73–3.27)

0.25

Clinical T stage

1.32 (0.59–2.94)

0.49

1.64 (0.48–5.55)

0.43

ADT

0.55 (0.31–0.99)

0.045

0.20 (0.07–.057)

0.002

Technique

0.13 (0.07–0.23)

<0.001

-----------

BED

-----------

0.987 (0.981–0.993)

<0.001

  1. PSA, Prostate-specific antigen; ADT, Androgen deprivation therapy; BED, Biological effective dose.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us